IL28B genotype is associated with cirrhosis or transition to cirrhosis in treatment-naive patients with chronic HCV genotype 1 infection: the international observational Gen-C study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2193-1801
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
IL28B genotype is associated with cirrhosis or transition to cirrhosis in treatment-naive patients with chronic HCV genotype 1 infection: the international observational Gen-C study ; volume:5 ; number:1 ; day:18 ; month:11 ; year:2016 ; pages:1-13 ; date:12.2016
SpringerPlus ; 5, Heft 1 (18.11.2016), 1-13, 12.2016
- Contributor
-
Mangia, Alessandra
Ledinghen, Victor De
Bailly, François
Brahm, Javier
Keiss, Jazeps
Valantinas, Jonas
Rasmann, Nele
Messinger, Diethelm
Tatsch, Fernando
Bakalos, Georgios
Foster, Graham R.
SpringerLink (Online service)
- DOI
-
10.1186/s40064-016-3663-6
- URN
-
urn:nbn:de:1111-201612099109
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 14.08.2025, 11:03 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mangia, Alessandra
- Ledinghen, Victor De
- Bailly, François
- Brahm, Javier
- Keiss, Jazeps
- Valantinas, Jonas
- Rasmann, Nele
- Messinger, Diethelm
- Tatsch, Fernando
- Bakalos, Georgios
- Foster, Graham R.
- SpringerLink (Online service)
Other Objects (12)
Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarray
HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a
Effect of laparoscopic splenectomy in patients with Hepatitis C and cirrhosis carrying IL28B minor genotype
Myelodysplastic syndrome in a patient with HCV cirrhosis. Case report
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study
Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b study
Prognostic value of liver stiffness in HIV/HCV-Coinfected patients with decompensated cirrhosis
Reliable resolution of ambiguous hepatitis C virus genotype 1 results with the Abbott HCV Genotype Plus RUO assay
Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis
Liver cirrhosis
Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis
Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarray
HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a
Effect of laparoscopic splenectomy in patients with Hepatitis C and cirrhosis carrying IL28B minor genotype
Myelodysplastic syndrome in a patient with HCV cirrhosis. Case report
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study
Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b study
Prognostic value of liver stiffness in HIV/HCV-Coinfected patients with decompensated cirrhosis
Reliable resolution of ambiguous hepatitis C virus genotype 1 results with the Abbott HCV Genotype Plus RUO assay
Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis
Liver cirrhosis
Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis
Gene expression profiling of HCV genotype 3a initial liver fibrosis and cirrhosis patients using microarray
HCV genotype-specific correlation with serum markers: Higher predictability for genotype 4a
Effect of laparoscopic splenectomy in patients with Hepatitis C and cirrhosis carrying IL28B minor genotype
Myelodysplastic syndrome in a patient with HCV cirrhosis. Case report
HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b
Safety and Effectiveness Using 8 Weeks of Glecaprevir/Pibrentasvir in HCV-Infected Treatment-Naïve Patients with Compensated Cirrhosis: The CREST Study
Ledipasvir/sofosbuvir for treatment-naive and treatment-experienced Chinese patients with genotype 1 HCV: an open-label, phase 3b study
Prognostic value of liver stiffness in HIV/HCV-Coinfected patients with decompensated cirrhosis
Reliable resolution of ambiguous hepatitis C virus genotype 1 results with the Abbott HCV Genotype Plus RUO assay
Efficacy and safety of glecaprevir/pibrentasvir in Japanese patients with chronic genotype 1 hepatitis C virus infection with and without cirrhosis
Liver cirrhosis